NCT03267277View on ClinicalTrials.gov

Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 5, 2017

Primary Completion Date

November 4, 2022

Study Completion Date

November 9, 2023

Conditions
DermatomyositisIdiopathic Inflammatory Myopathies
Interventions
DRUG

Sodium Thiosulfate

Sodium thiosulfate is a calcium chelator

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Environmental Health Sciences (NIEHS)

NIH

NCT03267277 - Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis | Biotech Hunter | Biotech Hunter